Literature DB >> 25805462

Incremental benefit of preoperative EUS for the detection of pancreatic neuroendocrine tumors: a meta-analysis.

Paul D James1, Apostolos V Tsolakis2, Mei Zhang3, Paul J Belletrutti4, Rachid Mohamed4, Derek J Roberts5, Steven J Heitman4.   

Abstract

BACKGROUND: Current guidelines recommend CT scan or magnetic resonance imaging as the initial imaging modalities for the work-up of suspected pancreatic neuroendocrine tumors (PNETs).
OBJECTIVE: To determine the incremental benefit of preoperative EUS (IBEUS) for the detection of suspected PNETs after other investigative modalities have been attempted.
DESIGN: This systematic review searched MEDLINE, EMBASE, bibliographies of included articles, and conference proceedings for studies reporting original data regarding the preoperative detection of PNETs. Pooled IBEUS was calculated by using random effects models. Heterogeneity was explored by using stratified meta-analysis and meta-regression. Evidence of small-study effects was assessed by using funnel plots and the Begg test. PATIENTS: Patients with suspected PNETs.
INTERVENTIONS: EUS evaluation. MAIN OUTCOME MEASUREMENTS: The pooled IBEUS for the detection of PNETs after CT scan, with or without additional investigative modalities.
RESULTS: Among 4505 citations identified, we included 17 cohort studies (612 patients). EUS identified PNETs in 97% of cases. Improved PNET identification with EUS was observed in all of the studies. After adjusting for small-study effects, meta-analysis showed that EUS alone could identify PNETs in approximately 1 in 4 patients (adjusted IBEUS 26%; 95% confidence interval, 17%-37%). The pooled IBEUS varied based on the study design, study size, type of CT scan used, and the number of modalities used prior to EUS. LIMITATIONS: The majority of included studies were retrospective. Small-study effects were observed.
CONCLUSION: Preoperative EUS is associated with an increase in PNET detection after other modalities are attempted.
Copyright © 2015 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25805462     DOI: 10.1016/j.gie.2014.12.031

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  20 in total

Review 1.  Recent advances in the diagnosis and management of pancreatic neuroendocrine tumours.

Authors:  Andrew D Hopper; Mustafa Jalal; Alia Munir
Journal:  Frontline Gastroenterol       Date:  2018-10-09

2.  The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.

Authors:  James R Howe; Nipun B Merchant; Claudius Conrad; Xavier M Keutgen; Julie Hallet; Jeffrey A Drebin; Rebecca M Minter; Terry C Lairmore; Jennifer F Tseng; Herbert J Zeh; Steven K Libutti; Gagandeep Singh; Jeffrey E Lee; Thomas A Hope; Michelle K Kim; Yusuf Menda; Thorvardur R Halfdanarson; Jennifer A Chan; Rodney F Pommier
Journal:  Pancreas       Date:  2020-01       Impact factor: 3.327

Review 3.  Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2018-07-17       Impact factor: 4.512

4.  Simple Vascular Architecture Classification in Predicting Pancreatic Neuroendocrine Tumor Grade and Prognosis.

Authors:  Ke Chen; Wenming Zhang; Zhaozhen Zhang; Yiping He; Yuan Liu; Xiujiang Yang
Journal:  Dig Dis Sci       Date:  2018-08-18       Impact factor: 3.199

5.  Regional differences in use of endoscopic ultrasonography in Ontario: a population-based retrospective cohort study.

Authors:  Paul D James; Mae Hegagi; Lilia Antonova; Jill Tinmouth; Steven J Heitman; Carmine Simone; Elaine Yeung; Elaine Yong
Journal:  CMAJ Open       Date:  2017-06-07

6.  Can MDCT or EUS features predict the histopathological grading scheme of pancreatic neuroendocrine neoplasms?

Authors:  Hui Zhu; Lang Ying; Wei Tang; Xiujiang Yang; Bo Sun
Journal:  Radiol Med       Date:  2017-02-07       Impact factor: 3.469

Review 7.  Transabdominal ultrasonographic diagnosis of relatively rare pancreatic neoplasms.

Authors:  Senju Hashimoto; Kazunori Nakaoka; Hiroyuki Tanaka; Teiji Kuzuya; Naoto Kawabe; Mitsuo Nagasaka; Yoshihito Nakagawa; Ryoji Miyahara; Tomoyuki Shibata; Yoshiki Hirooka
Journal:  J Med Ultrason (2001)       Date:  2022-02-12       Impact factor: 1.314

Review 8.  Management of neuroendocrine tumors of unknown primary.

Authors:  Krystallenia Alexandraki; Anna Angelousi; Georgios Boutzios; Georgios Kyriakopoulos; Dimitra Rontogianni; Gregory Kaltsas
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 9.  Diagnosis of Pancreatic Neuroendocrine Tumors.

Authors:  Dong Wook Lee; Michelle Kang Kim; Ho Gak Kim
Journal:  Clin Endosc       Date:  2017-11-30

Review 10.  Non-functioning pancreatic neuroendocrine tumors: Surgery or observation?

Authors:  Yehonatan Bar-Moshe; Haggi Mazeh; Simona Grozinsky-Glasberg
Journal:  World J Gastrointest Endosc       Date:  2017-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.